Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
FNA - Paragon 28, Inc.
Market Cap 1.40B P/E - EPS this Y 24.10% Ern Qtrly Grth -
Income -47.84M Forward P/E -60.79 EPS next Y 29.50% 50D Avg Chg -4.00%
Sales 216.39M PEG -0.75 EPS past 5Y - 200D Avg Chg -6.00%
Dividend N/A Price/Book 7.06 EPS next 5Y 29.80% 52W High Chg -21.00%
Recommedations 1.60 Quick Ratio 2.22 Shares Outstanding 82.91M 52W Low Chg 9.00%
Insider Own 39.89% ROA -7.84% Shares Float 39.20M Beta 1.01
Inst Own 49.63% ROE -30.03% Shares Shorted/Prior 3.41M/1.86M Price 17.02
Gross Margin 79.85% Profit Margin -22.11% Avg. Volume 267,703 Target Price 18.00
Oper. Margin -18.54% Earnings Date - Volume 231,603 Change -1.16%
Healthcare | Medical Devices | United States
About Paragon 28, Inc.

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Paragon 28, Inc. News
04/12/24 Paragon 28, Inc. (NYSE:FNA) has caught the attention of institutional investors who hold a sizeable 36% stake
04/04/24 Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
04/01/24 Paragon 28 (FNA) Expands Syndesmotic Repair Line With New Launch
03/28/24 Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
03/28/24 Paragon 28, Inc. (FNA) Moves 16.2% Higher: Will This Strength Last?
03/02/24 Paragon 28, Inc. (NYSE:FNA) Q4 2023 Earnings Call Transcript
03/02/24 Paragon 28 Full Year 2023 Earnings: EPS Misses Expectations
03/01/24 Q4 2023 Paragon 28 Inc Earnings Call
02/29/24 Paragon 28 Inc (FNA) Reports Growth and Sets Positive Outlook for 2024
02/29/24 Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance
02/17/24 Paragon 28 Insider Ups Holding During Year
02/12/24 Paragon 28 to Present at the CG 2024 Musculoskeletal Conference
02/08/24 Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Top Estimates
02/06/24 Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
02/01/24 Paragon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions
01/30/24 Paragon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle Procedures
01/26/24 Paragon 28 Launches the Mister Tendon™ Harvester System – The First and Only Minimally Invasive Harvesting System for FHL and FDL Tendon Transfer Procedures
01/17/24 Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures
01/08/24 Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023
01/05/24 Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape
FNA Chatroom

User Image Losingmoneyprobably Posted - 3 weeks ago

$FNA Order to buy at $10, we’ll see if it goes through. Interesting stock

User Image BC91 Posted - 3 weeks ago

$FNA drop to 10??

User Image Thestocktraderhubzee Posted - 3 weeks ago

$FNA Needham Reiterates Buy on Paragon 28, Maintains $17 Price Target

User Image DonCorleone77 Posted - 3 weeks ago

$FNA Paragon 28 reaffirms FY24 revenue $249M-$259M, consensus $253.92M The Company reaffirms its prior 2024 net revenue guidance and continues to expect 2024 net revenue to be $249 million to $259 million, representing 15.1% and 19.7% reported growth compared to 2023. The Company's 2024 net revenue guidance assumes foreign currency translation rates remain consistent with current foreign currency translation rates, and further, is based on a number of assumptions that are subject to change, many of which are outside the Company's control. If actual results vary from these assumptions, the Company's expectations may change. There can be no assurance that the Company will achieve these results.

User Image DonCorleone77 Posted - 3 weeks ago

$FNA Paragon 28 reports preliminary Q1 revenue $60.8M-$61.1M, consensus $58.74M Preliminary unaudited net revenue for the first quarter of 2024 is expected to be in a range of $60.8 to $61.1 million, representing reported growth of approximately 16.8% to 17.4% compared to the first quarter of 2023. Foreign currency impact on first quarter 2024 reported net revenue growth is not expected to be immaterial.

User Image Stock_Titan Posted - 3 weeks ago

$FNA Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024 https://www.stocktitan.net/news/FNA/paragon-28-announces-cfo-transition-provides-preliminary-unaudited-yo4sisk64yn0.html

User Image Stock_Titan Posted - 03/28/24

$FNA Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System https://www.stocktitan.net/news/FNA/paragon-28-adds-to-suite-of-novel-syndesmosis-repair-solutions-with-tbmk0xllsu0c.html

User Image Ninja_Tradez Posted - 1 month ago

📢 $FNA - Needham Maintains Buy on Paragon 28, Raises Price Target to $17 https://newsfilter.io/a/16dd1d66321b6e452e10fd0be5d3e76e

User Image DonCorleone77 Posted - 02/29/24

$FNA Paragon 28 reports Q4 revenue $60.6M, consensus $60.46M "Our team ended the year with solid performances across each foot and ankle segment both in the U.S. and International markets," said Albert DaCosta, Chairman and Chief Executive Officer. "Turning to 2024, we are incredibly excited to launch several new and high-impact solutions to start the year. Our continued growth is proof of our ability to address unmet needs in the foot and ankle market by committing to innovation and improving patient outcomes."

User Image Stock_Titan Posted - 02/29/24

$FNA Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance https://www.stocktitan.net/news/FNA/paragon-28-reports-fourth-quarter-and-full-year-2023-financial-b2gwjaqty3et.html

User Image TickerDD_com Posted - 02/26/24

From 2/16/2024, looking back across 22 Month-Ends for FNA, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $FNA #FNA #FNAStock #TickerDD #FNAPrice https://www.youtube.com/watch?v=ZA_cHctxiv8

User Image AnonMav Posted - 2 months ago

I spotted both a Head and Shoulders Bottom and a Megaphone Bottom on $FNA alongside a 14% increase in net income, a 20% improvement in EPS, and a 14% rise in revenues. The target is $15 by May and $18+ by August. The options chain is dead so commons would likely be the way to swing this.

User Image Stock_Titan Posted - 2 months ago

$FNA Paragon 28 to Present at the CG 2024 Musculoskeletal Conference https://www.stocktitan.net/news/FNA/paragon-28-to-present-at-the-cg-2024-musculoskeletal-cfyk4s7t8lfr.html

User Image Stock_Titan Posted - 2 months ago

$FNA Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 https://www.stocktitan.net/news/FNA/paragon-28-to-report-fourth-quarter-and-full-year-2023-financial-3pg0oup86m7j.html

User Image StockAutomatePro Posted - 3 months ago

$FNA Stock is looking strong and set to rise based on the chart. We alerted the BUY signal at $10.91 and we were able to close this one with profit at $12.05🤙 See more details at StockAutomate.com

User Image StockAutomatePro Posted - 3 months ago

$FNA Good news for investors chart analysis shows upward momentum. We alerted the BUY signal at $10.91 and we were able to close this one with profit at $11.87 💖

User Image EarningsInsider Posted - 3 months ago

$FNA updates Q4 2023 guidance to EPS and revenue guidance to $60.3 million-$60.6 million. www.marketbeat.com/stocks/NYSE/FNA/earnings/

User Image EarningsInsider Posted - 3 months ago

$FNA updates FY 2023 guidance to EPS and revenue guidance to $216.1 million-$216.4 million. www.marketbeat.com/stocks/NYSE/FNA/earnings/

User Image Last10K Posted - 3 months ago

$FNA just filed with the SEC a Earnings Release and a Financial Exhibit https://last10k.com/sec-filings/FNA/0001193125-24-003996.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=FNA

User Image cctranscripts Posted - 3 months ago

Paragon 28, Inc. just filed its Current report, items 2.02 and 9.01 http://www.sec.gov/Archives/edgar/data/1531978/000119312524003996/0001193125-24-003996-index.htm $FNA

User Image risenhoover Posted - 3 months ago

$FNA / Paragon 28 files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 08, 2024 Paragon 28, Inc. https://fintel.io/doc/sec-paragon-28-inc-1531978-8k-2024-january-08-19730-9263?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Stock_Titan Posted - 3 months ago

$FNA Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 https://www.stocktitan.net/news/FNA/paragon-28-announces-preliminary-unaudited-revenue-for-fourth-4tcpmlwgstyu.html

User Image dividendinvestorbyeagle Posted - 3 months ago

$FNA close increased > 10% (Paragon 28 Inc) https://www.dividendinvestor.com/dividend-news/?symbol=fna http://dlvr.it/T139c3

User Image StockAutomatePro Posted - 3 months ago

$FNA Looks like the stock is headed for a period of growth according to the chart. We alerted the BUY signal at $12.13 and we were able to close this one with profit at $13.08 🥳

User Image Stock_Titan Posted - 3 months ago

$FNA Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape https://www.stocktitan.net/news/FNA/paragon-28-advances-foot-and-ankle-specific-soft-tissue-portfolio-lv5ynr1nh5gl.html

User Image StockAutomatePro Posted - 12/27/23

$FNA Positive news for stockholders chart shows upward trend. We alerted the BUY signal at $12.15 and we were able to close this one with profit at $13.13 📊 See more details at StockAutomate.com

User Image tickeron Posted - 12/26/23

Bulls or bears - who will win? $FNA in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://srnk.us/go/4951796

User Image Stock_Titan Posted - 4 months ago

$FNA Paragon 28 to Present at the 42nd Annual J.P. Morgan Healthcare Conference https://www.stocktitan.net/news/FNA/paragon-28-to-present-at-the-42nd-annual-j-p-morgan-healthcare-opaqwd0md88y.html

User Image cctranscripts Posted - 4 months ago

Paragon 28, Inc. insider just disposed of 5,700 shares https://www.conferencecalltranscripts.org/summary/?id=12767909 $FNA

User Image cctranscripts Posted - 4 months ago

Paragon 28, Inc. insider just disposed of 20,628 shares https://www.conferencecalltranscripts.org/summary/?id=12767908 $FNA

Analyst Ratings
Stephens & Co. Overweight Apr 5, 24
Needham Buy Apr 4, 24
Needham Buy Mar 28, 24
Piper Sandler Overweight Mar 27, 24
Needham Buy Mar 1, 24
Needham Buy Nov 8, 23
William Blair Outperform Sep 29, 23
Needham Buy Aug 3, 23
JMP Securities Market Outperform May 5, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
DaCosta Albert see remarks see remarks Nov 10 Buy 8.51 30,500 259,555 5,311,110 11/13/23
SCHNETTLER THOMAS P Director Director Jun 14 Sell 18.5437 6,900 127,952 29,129 06/16/23
Friedman Jonathan I Other Other Nov 25 Sell 20.42 15,000 306,300 52,054 06/08/23
Friedman Jonathan I Other Other Nov 25 Option 13.71 15,000 205,650 54,554 06/08/23
WRIGHT KRISTINA Director Director Jun 06 Sell 18.5801 6,800 126,345 24,641 06/08/23
DaCosta Albert See Remarks See Remarks Feb 17 Sell 17 150,000 2,550,000 25,000 02/22/23
Jarboe Matthew Chief Commercial Off.. Chief Commercial Officer Dec 23 Sell 20.93 35,110 734,852 271,764 12/27/22
Jarboe Matthew Chief Commercial Off.. Chief Commercial Officer Dec 23 Option 1.2 35,110 42,132 306,874 12/27/22
Jarboe Matthew Chief Commercial Off.. Chief Commercial Officer Dec 20 Sell 20.91 87,012 1,819,421 271,764 12/23/22
Jarboe Matthew Chief Commercial Off.. Chief Commercial Officer Dec 20 Option 0.8 87,012 69,610 296,677 12/23/22
MVM Partners LLP 10% Owner 10% Owner Dec 19 Sell 20.4161 9,597 195,933 139,659,625 12/21/22
MVM Partners LLP 10% Owner 10% Owner Dec 08 Sell 20.18 44,146 890,866 13,681,400 12/12/22
DaCosta Albert See Remarks See Remarks Dec 01 Sell 19.5141 30,000 585,423 379,136 12/02/22
MVM Partners LLP 10% Owner 10% Owner Nov 23 Sell 20.13 987 19,868 13,756,746 11/25/22
Rosenthal Lee - - Nov 07 Sell 18.4824 61,001 1,127,445 75,607 11/08/22
Rosenthal Lee 10% Owner 10% Owner Jul 20 Option 2.8 247,810 693,868 693,471 10/31/22
Rosenthal Lee 10% Owner 10% Owner Jul 20 Sell 18.95 691,774 13,109,117 663,723 10/31/22
MVM Partners LLP 10% Owner 10% Owner Oct 04 Sell 19.0936 1,517 28,965 13,876,730 10/06/22
MVM Partners LLP 10% Owner 10% Owner Sep 20 Sell 18.68 36,421 680,344 13,878,247 09/22/22
MVM Partners LLP 10% Owner 10% Owner Sep 13 Sell 18.93 52,810 999,693 13,922,551 09/15/22
MVM Partners LLP 10% Owner 10% Owner Sep 09 Sell 18.88 81,231 1,533,641 13,975,361 09/13/22
DaCosta Albert See Remarks See Remarks Sep 08 Sell 18.0069 30,000 540,207 202,890 09/09/22
MVM Partners LLP 10% Owner 10% Owner Aug 26 Sell 18.7775 800 15,022 14,056,592 08/30/22
MVM Partners LLP 10% Owner 10% Owner Aug 24 Sell 18.64 30,000 559,200 14,057,392 08/26/22
MVM Partners LLP 10% Owner 10% Owner Aug 15 Sell 20.06 32,301 647,958 14,087,392 08/17/22
Jarboe Matthew Chief Commercial Off.. Chief Commercial Officer Aug 11 Option 0.6 2,878 1,727 228,173 08/15/22
Jarboe Matthew Chief Commercial Off.. Chief Commercial Officer Aug 11 Sell 20.94 27,878 583,765 200,295 08/15/22
MVM Partners LLP 10% Owner 10% Owner Aug 10 Sell 20.57 144,099 2,964,116 14,119,693 08/12/22
MVM Partners LLP 10% Owner 10% Owner Aug 08 Sell 19.5 68,303 1,331,908 14,263,792 08/10/22
MVM Partners LLP 10% Owner 10% Owner Aug 04 Sell 19.32 82,100 1,586,172 14,332,095 08/08/22
Jarboe Matthew Chief Commercial Off.. Chief Commercial Officer Jul 14 Sell 19.01 86,111 1,636,970 225,295 07/15/22
Jarboe Matthew Chief Commercial Off.. Chief Commercial Officer Jul 08 Sell 19.4433 63,889 1,242,213 311,406 07/11/22
Bono Frank S. Chief Technology Off.. Chief Technology Officer Jun 06 Sell 18.74 20,000 374,800 1,661,104 06/08/22
Bono Frank S. Chief Technology Off.. Chief Technology Officer May 27 Sell 18 25,000 450,000 1,641,104 06/01/22